Our next set of drug reports deals with specialty drugs, the most expensive and fastest growing category, and one which has bedeviled payers but many of the drugs are covered…
Read More
The first analysis of a weeklong series on recent reports related to aspects of the pharmaceutical industry covers IMS' report giving projections on aspects of global drug use and spending…
Read More
Our current Potpourri features Google's dropping of its PHR, the AMA's report on insurer claims paying, the role of health advocacy groups, employer's intentions in regard to offering health coverage,…
Read More
A Rand report examines how self-insured employers might be affected by the PPACA, finding it unlikely that small employers will significantly shift to self-funding. The report also finds little reason…
Read More
A study finds that using home health care after a hospital admission for Medicare beneficiaries with certain chronic illnesses reduces Medicare Part A spending and readmissions compared to a beneficiary…
Read More
Deloitte issues the results of a global and a United States consumer survey on perceptions of health and health care system. Most Americans have a gloomy outlook, but so do…
Read More
Fireworks galore for the Fourth of July Potpourri, including dynamite excerpts on the effects of parent caregiving on caregivers' financial status; health insurance exchanges; physician compensation; provider performance data gathering…
Read More
The second annual report by the Massachusetts AG on health care spending trends continues to find that provider market power is a major factor and that using a risk-based payment…
Read More
Two articles describe in detail how Britain's NICE operates in creating guidelines and conducting cost-effectiveness reviews. The process is highly transparent and professional, and while the institution has taken criticism…
Read More
AHRQ issued yet another detailed, informative evidence review, this one on use of health information technology for medication management purposes. While many studies exist, the strength of the evidence for…
Read More